Supernus Pharmaceuticals(SUPN) - 2024 Q4 - Earnings Call Transcript

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Peter Vozzo – Investor Relations-ICR Healthcare Jack Khattar – Chief Executive Officer Tim Dec – Chief Financial Officer Conference Call Participants Andrew Tsai – Jefferies Stacy Ku – TD Cowen Annabel Samimy - Stifel David Amsellem – Piper Sandler Kristen Kluska - Cantor Fitzgerald Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2024 F ...